Tarsus Pharmaceuticals, Inc.

NASDAQ:TARS

52.91 (USD) • At close December 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018
Operating Activities:
Net Income -135.893-62.091-13.827-26.811-4.67-1.319
Depreciation & Amortization 0.8770.3250.3120.0960.0370.001
Deferred Income Tax 001.6460.0150.3310
Stock Based Compensation 19.8313.468.4550.8390.0180.009
Change In Working Capital 0.306-0.9511.3721.4580.4850.126
Accounts Receivables -14.131-3.49-0.0730.016-0.032-0.004
Inventory -3.1073.490.073-0.0160.0320
Accounts Payables 13.240.8213.883.240.2450.131
Other Working Capital 4.304-1.772-2.508-1.7820.24-0.005
Other Non Cash Items -2.6130.2275.793.2650.126-0.116
Operating Cash Flow -117.493-49.033.748-21.138-3.673-1.183
Investing Activities:
Investments In Property Plant And Equipment -1.502-0.506-0.586-0.456-0.175-0.007
Acquisitions Net 0144.1230000
Purchases Of Investments -28.664-149.4380000
Sales Maturities Of Investments 174.775.3150000
Other Investing Activites -4-144.1230000
Investing Cash Flow 140.604-144.629-0.586-0.456-0.175-0.007
Financing Activities:
Debt Repayment 1020001.9890
Common Stock Issued 118.59974.3525.49491.67357.4563.564
Common Stock Repurchased 000-0.02800
Dividends Paid 000000
Other Financing Activities 1.577-0.3650.02140.09857.4563.564
Financing Cash Flow 130.17693.9870.021131.77159.4453.564
Other Information:
Effect Of Forex Changes On Cash 000000
Net Change In Cash 153.287-99.6723.183110.17755.5972.374
Cash At End Of Period 224.94771.66171.332168.14957.9722.375